Background: Vitiligo is a common and visible form of leukoderma that can adversely affect the quality of life of patients. The aim of this study was to assess the impact of vitiligo on the quality of life of patients.
Patients And Methods: This was a cross-sectional case-control study performed between 1 September 2000 and 31 December 2001.
Background: Inhibitors of epidermal growth factor receptors (EGFR) constitute a new alternative treatment for patients presenting certain advanced stage solid cancers (bowel, breast, ovary). Adverse cutaneous effects of these drugs are now starting to be described.
Observations: Our study involved 2 men and 2 women with no previous history of acne included in a treatment protocol comprising EGFR inhibitors.